ECO ANIMAL HLTH GR.LS-05 risk profile
38 Normal where most of the sector sits
Measured 21 October 2026 from LWA's filed statements. Recomputed nightly.
38 (Normal), driven by Competitive position at 47, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 45 | Elevated | Stable | Average daily turnover — $4.4K |
| Operating pressure | 42 | Elevated | Stable | Costs outgrowing revenue — +0.4 percentage points |
| Cash conversion | 27 | Normal | Stable | Capital spending against operating cash — 0.48x |
| Leverage and coverage | 7 | Contained | Easing | Current ratio — 3.21x |
| Competitive position | 47 | Elevated | Stable | Revenue-growth gap against peers — -19.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for ECO ANIMAL HLTH GR.LS-05